Dr Reddy's Laboratories Ltd (NYSE:RDY)
$ 15.6 -0.07 (-0.45%) Market Cap: 13.05 Bil Enterprise Value: 12.93 Bil PE Ratio: 25.11 PB Ratio: 3.70 GF Score: 91/100

Half Year 2025 Dr Reddy's Laboratories Ltd Earnings Call Transcript

Nov 05, 2024 / 02:00PM GMT
Release Date Price: $14.61 (-1.27%)
Operator

Ladies and gentlemen, good day and welcome to the quarter two FY25 earnings conference call of Dr. Reddy's Laboratories Limited. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Ms. Richa Periwal. Thank you and over to you, ma'am.

Richa Periwal;s Laboratories Limited;Investor Relations
Dr. Reddy

'-

Thank you. A very good morning and good evening to all of you, and thank you for joining us today for the Dr. Reddy's Q2 FY25 earnings conference call. We have with us the leadership team of Dr. Reddy's comprising Mr. Erez Israeli, our CEO; Mr. M V Narasimham, our CFO, whom we formally called as MVN and the Investor Relations team.

Earlier during the day, we have released our results, and the same is also posted on our website. We kick off today's call with MVN taking us through the financial highlights of the quarter. This will be followed by Erez, sharing his thoughts on operating environment and business performance, post which, we open the forum for Q

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot